Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Deleobuvir and Faldaprevir in Japanese Treatment-naïve GT-1 HCV Patients
NCT01528735Phase 2Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Feb 2012
- Primary completion
- Aug 2013
- Modality
- Small Molecules, Modified Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of deleobuvir, faldaprevir in hepatitis C virus infection, sponsored by Boehringer Ingelheim. Started Feb 2012; status: completed.
02
Drugs
deleobuvirfaldaprevir
03
Conditions
hepatitis C virus infection
Beyond the preview
Go deeper on NCT01528735.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01528735.